CoChat

Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP

Skalska, Lenka, White, Robert E., Franz, Melanie, Ruhmann, Michaela, Allday, Martin J. · 2010 · PLoS Pathogens
Cited by 136

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1000951

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 57

  1. GW Bornkamm, 2001, Molecular virology of Epstein-Barr virus., Philos Trans R Soc Lond B Biol Sci, 356, 437, 10.1098/rstb.2000.0781 · DOI
  2. DA Thorley-Lawson, 2004, Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas., The New England journal of medicine, 350, 1328, 10.1056/NEJMra032015 · DOI · Paper page
  3. JE Roughan, 2009, The intersection of Epstein-Barr virus with the germinal center., J Virol, 83, 3968, 10.1128/JVI.02609-08 · doi:10.1128/jvi.02609-08
  4. DH Crawford, 2001, Biology and disease associations of Epstein-Barr virus., Philos Trans R Soc Lond B Biol Sci, 356, 461, 10.1098/rstb.2000.0783 · DOI · Paper page
  5. R Touitou, 2005, Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells., J Gen Virol, 86, 1269, 10.1099/vir.0.80763-0 · DOI
  6. B Tomkinson, 1993, Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation., J Virol, 67, 2014, 10.1128/JVI.67.4.2014-2025.1993 · DOI · Paper page
  7. B Tomkinson, 1992, Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro., J Virol, 66, 2893, 10.1128/JVI.66.5.2893-2903.1992 · doi:10.1128/jvi.66.5.2893-2903.1992
  8. ML Hertle, 2009, Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes., PLoS Pathogens, 5, e1000506, 10.1371/journal.ppat.1000506 · DOI
  9. A Le Roux, 1994, The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter., Virology, 205, 596, 10.1006/viro.1994.1687 · doi:10.1006/viro.1994.1687
  10. L Waltzer, 1996, Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA., J Virol, 70, 5909, 10.1128/JVI.70.9.5909-5915.1996 · doi:10.1128/jvi.70.9.5909-5915.1996
  11. SA Radkov, 1999, Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription., J Virol, 73, 5688, 10.1128/JVI.73.7.5688-5697.1999 · DOI
  12. I Cludts, 1998, Multiple functions within the Epstein-Barr virus EBNA-3A protein., J Virol, 72, 1862, 10.1128/JVI.72.3.1862-1869.1998 · doi:10.1128/jvi.72.3.1862-1869.1998
  13. M Bain, 1996, Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA., J Virol, 70, 2481, 10.1128/JVI.70.4.2481-2489.1996 · DOI
  14. PY Bourillot, 1998, Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa., J Gen Virol, 79 (Pt2), 363, 10.1099/0022-1317-79-2-363 · doi:10.1099/0022-1317-79-2-363
  15. JS Knight, 2003, Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines., J Virol, 77, 4261, 10.1128/JVI.77.7.4261-4272.2003 · DOI
  16. R Touitou, 2001, Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C., J Virol, 75, 7749, 10.1128/JVI.75.16.7749-7755.2001 · DOI
  17. M Hickabottom, 2002, Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP)., J Biol Chem, 277, 47197, 10.1074/jbc.M208116200 · DOI
  18. G Chinnadurai, 2007, Transcriptional regulation by C-terminal binding proteins., Int J Biochem Cell Biol, 39, 1593, 10.1016/j.biocel.2007.01.025 · DOI · Paper page
  19. Y Shi, 2003, Coordinated histone modifications mediated by a CtBP co-repressor complex., Nature, 422, 735, 10.1038/nature01550 · DOI · Paper page
  20. A Dahiya, 2001, Linking the Rb and polycomb pathways., Mol Cell, 8, 557, 10.1016/S1097-2765(01)00346-X · DOI · Paper page
  21. EA Mroz, 2008, COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells., Cancer Res, 68, 6049, 10.1158/0008-5472.CAN-08-1279 · DOI
  22. GA Parker, 1996, Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7., Oncogene, 13, 2541
  23. GA Parker, 2000, Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis., Oncogene, 19, 700, 10.1038/sj.onc.1203327 · DOI
  24. T Choudhuri, 2007, The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block., J Virol, 81, 6718, 10.1128/JVI.00053-07 · DOI
  25. B Gruhne, 2009, Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints., Oncogene, 28, 3997, 10.1038/onc.2009.258 · DOI · Paper page
  26. JS Knight, 2004, Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity., J Virol, 78, 1981, 10.1128/JVI.78.4.1981-1991.2004 · DOI
  27. JS Knight, 2005, Epstein–Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase., Proc Natl Acad Sci U S A, 102, 18562, 10.1073/pnas.0503886102 · DOI · Paper page
  28. JS Knight, 2005, SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen., Mol Cell Biol, 25, 1749, 10.1128/MCB.25.5.1749-1763.2005 · DOI
  29. BG Bajaj, 2008, Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein., J Virol, 82, 4082, 10.1128/JVI.02500-07 · DOI
  30. A Saha, 2009, Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2., J Virol, 83, 4652, 10.1128/JVI.02408-08 · DOI
  31. F Yi, 2009, Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities., Virology, 388, 236, 10.1016/j.virol.2009.03.027 · DOI
  32. S Maruo, 2006, Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells., Proc Natl Acad Sci U S A, 103, 19500, 10.1073/pnas.0604919104 · DOI · Paper page
  33. S Maruo, 2003, Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth., J Virol, 77, 10437, 10.1128/JVI.77.19.10437-10447.2003 · doi:10.1128/jvi.77.19.10437-10447.2003
  34. E Anderton, 2008, Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma., Oncogene, 27, 421, 10.1038/sj.onc.1210668 · DOI · Paper page
  35. K Paschos, 2009, Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim., PLoS Pathogens, 5, e1000492, 10.1371/journal.ppat.1000492 · DOI · Paper page
  36. JA Simon, 2009, Mechanisms of Polycomb gene silencing: knowns and unknowns., Nat Rev Mol Cell Biol, 10, 697, 10.1038/nrm2763 · DOI · Paper page
  37. AP Bracken, 2009, Polycomb group proteins: navigators of lineage pathways led astray in cancer., Nat Rev Cancer, 9, 773, 10.1038/nrc2736 · DOI · Paper page
  38. HJ Delecluse, 1998, Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells., Proc Natl Acad Sci U S A, 95, 8245, 10.1073/pnas.95.14.8245 · DOI · Paper page
  39. RE White, 2003, Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence., J Gen Virol, 84, 3393, 10.1099/vir.0.19387-0 · doi:10.1099/vir.0.19387-0
  40. B Neuhierl, 2002, Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection., Proc Natl Acad Sci U S A, 99, 15036, 10.1073/pnas.232381299 · DOI
  41. SK Kia, 2008, SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus., Mol Cell Biol, 28, 3457, 10.1128/MCB.02019-07 · DOI · Paper page
  42. RG Sewalt, 1999, C-Terminal Binding Protein Is a Transcriptional Repressor That Interacts with a Specific Class of Vertebrate Polycomb Proteins., Mol Cell Biol, 19, 777, 10.1128/MCB.19.1.777 · DOI · Paper page
  43. L Atchison, 2003, Transcription factor YY1 functions as a PcG protein in vivo., EMBO Journal, 22, 1347, 10.1093/emboj/cdg124 · DOI · Paper page
  44. L Srinivasan, 2004, YY1 DNA binding and PcG recruitment requires CtBP., Genes Dev, 18, 2596, 10.1101/gad.1228204 · DOI
  45. AV Krivtsov, 2007, MLL translocations, histone modifications and leukaemia stem-cell development., Nature Rev Cancer, 7, 823, 10.1038/nrc2253 · DOI · Paper page
  46. VK Tiwari, 2008, PcG proteins, DNA methylation, and gene repression by chromatin looping., PLoS Biology, 6, 2911, 10.1371/journal.pbio.0060306 · DOI · Paper page
  47. S Mujtaba, 2008, Epigenetic transcriptional repression of cellular genes by a viral SET protein., Nat Cell Biol, 10, 1114, 10.1038/ncb1772 · DOI
  48. N Ohtani, 2003, Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5., J Cell Biol, 162, 173, 10.1083/jcb.200302085 · DOI · Paper page
  49. I Keshet, 2006, Evidence for an instructive mechanism of de novo methylation in cancer cells., Nat Genet, 38, 149, 10.1038/ng1719 · DOI · Paper page
  50. U Klangby, 1998, p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma., Blood, 91, 1680, 10.1182/blood.V91.5.1680 · DOI
  51. MS Lindstrom, 2002, Role of genetic and epigenetic changes in Burkitt lymphoma., Semin Cancer Biol, 12, 381, 10.1016/S1044-579X(02)00058-5 · DOI
  52. I Hernandez-Munoz, 2005, Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1., Mol Cell Biol, 25, 11047, 10.1128/MCB.25.24.11047-11058.2005 · DOI · Paper page
  53. U Schaeper, 1995, Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation., Proc Natl Acad Sci U S A, 92, 10467, 10.1073/pnas.92.23.10467 · DOI · Paper page
  54. AC Brown, 2006, Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus., Proc Natl Acad Sci U S A, 103, 1687, 10.1073/pnas.0507595103 · doi:10.1073/pnas.0507595103
  55. S Lee, 2009, Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1., J Virol, 83, 12368, 10.1128/JVI.01403-09 · DOI
  56. S Maruo, 2009, Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth., Proc Natl Acad Sci U S A, 106, 4419, 10.1073/pnas.0813134106 · doi:10.1073/pnas.0813134106
  57. PM Howley, 2009, Small DNA tumor viruses: large contributors to biomedical sciences., Virology, 384, 256, 10.1016/j.virol.2008.12.006 · DOI · Paper page

Cited by

Metadata

Authors
Skalska, L., White, R. E., Franz, M., Ruhmann, M., & Allday, M. J.
Venue
PLoS Pathogens
Published
2010-06-10
Volume
6
Issue
6
Pages
e1000951
ISSN
1553-7374
Cited by
136
References
14
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.